Skip to main content
. 2017 Aug 14;48(3):307–312. doi: 10.1097/SHK.0000000000000851

Table 2.

Hemodynamic variables

Variables Groups Baseline 24 h 48 h 72 h
Heart rate (bpm) Control 92 [84–102] 101 [90–112] 105 [92–121] 94 [82–108]
Levo 102 [80–110] 108 [90–116] 108 [82–118] 103 [81–112]
MAP (mm Hg) Control 73 [62–86] 80 [68–91] 78 [67–85] 73 [60–87]
Levo 74 [60–84] 77 [65–91] 77 [60–88] 81 [74–94]
CI (l/min/m2) Control 3.5 [3.2–4.4] 4.1 [3.7–4.9] 4.2 [3.8–5.1] 4 [3.1–4.9]
Levo 4 [3–4.6] 4.5 [3.6–5.2] 4.4 [3.8–5.4] 4.7 [3.9–5.2]
CVP (mm Hg) Control 10.2 [9–11.1] 9.2 [8.1–11.3] 10.5 [9–12.2] 10 [8.9–12.1]
Levo 9.5 [8.2–10.9] 10.3 [9–12.1] 12.1 [10–13.4] 11[10.3–12.4]
DO2I (ml/min/m2) Control 452 [387–532] 539 [402–631] 623.9 [567–730] 538.8 [497–602]
Levo 546 [497–646] 594 [477–652] 588 [497–629] 611 [507–694]
VO2I (mL/min/m2) Control 143 [87–212] 156 [94–282] 161 [94–302] 149 [76–227]
Levo 151 [71–231] 167 [80–272] 159 [77–287] 141 [81–294]
O2-ER (%) Control 26 [20–34] 25 [20–32] 26 [21–35] 28 [21–37]
Levo 24 [19–32] 27[22–33] 25 [19–38] 26 [18–36]
NE Dose (μg/kg/min) Control 0.2 [0.1–0.7] 0.27 [0.1–0.6] 0.25 [0.1–0.8] 0.29 [0.08–0.9]
Levo 0.3 [0.1–0.8] 0.34 [0.2–0.9] 0.31[0.18–1.1] 0.29 [0.1–1]
Glycemia (mmol/L) Control 12 [11.1–12.8] 10.3 [9–11.8] 10.8 [9.1–12.9] 10.1 [9.2–11.8]
Levo 10.7 [9.1–12.4] 11.8 [10.1–12.9] 10.4 [8.9–12.4] 9.7 [8.7–10.9]
Fluid input, mL/24 h Control 1,010 [902–1,220] 898 [778–1,120] 895 [778–1,129] 890 [778–1,001]
Levo 1,185 [1,078–1,328] 997 [842–1,200] 912 [808–1,190] 909 [838–1,124]

Data are presented as median [25th; 75th percentile]. No statistically significant differences were found in any of the investigated variables.

CI indicates cardiac index; CVP, central venous pressure; DO2I, systemic oxygen delivery index; MAP, mean arterial pressure; NE, norepinephrine; O2-ER, oxygen extraction ratio; VO2I, oxygen consumption index.